BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10490596)

  • 1. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.
    Fenrick R; Amann JM; Lutterbach B; Wang L; Westendorf JJ; Downing JR; Hiebert SW
    Mol Cell Biol; 1999 Oct; 19(10):6566-74. PubMed ID: 10490596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.
    Heibert SW; Lutterbach B; Durst K; Wang L; Linggi B; Wu S; Wood L; Amann J; King D; Hou Y
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S31-4. PubMed ID: 11587363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of transcriptional repression by TEL/RUNX1 fusion protein.
    Lee YJ; Kim JH; Bae S; Rho SK; Choe SY
    Mol Cells; 2004 Apr; 17(2):217-22. PubMed ID: 15179033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription.
    Hiebert SW; Sun W; Davis JN; Golub T; Shurtleff S; Buijs A; Downing JR; Grosveld G; Roussell MF; Gilliland DG; Lenny N; Meyers S
    Mol Cell Biol; 1996 Apr; 16(4):1349-55. PubMed ID: 8657108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
    Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
    Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein.
    Lutterbach B; Sun D; Schuetz J; Hiebert SW
    Mol Cell Biol; 1998 Jun; 18(6):3604-11. PubMed ID: 9584201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
    Amann JM; Nip J; Strom DK; Lutterbach B; Harada H; Lenny N; Downing JR; Meyers S; Hiebert SW
    Mol Cell Biol; 2001 Oct; 21(19):6470-83. PubMed ID: 11533236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor.
    Lutterbach B; Hou Y; Durst KL; Hiebert SW
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12822-7. PubMed ID: 10536006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.
    Shurtleff SA; Buijs A; Behm FG; Rubnitz JE; Raimondi SC; Hancock ML; Chan GC; Pui CH; Grosveld G; Downing JR
    Leukemia; 1995 Dec; 9(12):1985-9. PubMed ID: 8609706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
    Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
    Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
    Wang J; Hoshino T; Redner RL; Kajigaya S; Liu JM
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10860-5. PubMed ID: 9724795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.
    Lutterbach B; Westendorf JJ; Linggi B; Patten A; Moniwa M; Davie JR; Huynh KD; Bardwell VJ; Lavinsky RM; Rosenfeld MG; Glass C; Seto E; Hiebert SW
    Mol Cell Biol; 1998 Dec; 18(12):7176-84. PubMed ID: 9819404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein.
    Guidez F; Petrie K; Ford AM; Lu H; Bennett CA; MacGregor A; Hannemann J; Ito Y; Ghysdael J; Greaves M; Wiedemann LM; Zelent A
    Blood; 2000 Oct; 96(7):2557-61. PubMed ID: 11001911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
    Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
    Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of TEL proteins in human leukemias.
    Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
    Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
    Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
    Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.